Anastacia: A Cancer Survivor Shares Her Story

“Sometimes things are going to happen that you don’t expect. You can’t fit yourself into a mold. Everyone fits a pant differently; everyone’s spirit absorbs things differently, so how could we heal the same?” Anastacia,

In her words and music, international singer and songwriter Anastacia is a strong and commanding presence. She is also a cancer survivor. For her, weathering treatment meant accepting the individuality of her experience and its side effects, and she reminds others that everyone’s process with cancer is unique: “Sometimes things are going to happen that you don’t expect. You can’t fit yourself into a mold. Everyone fits a pant differently; everyone’s spirit absorbs things differently, so how could we heal the same?”
Ultimately, Anastacia faced cancer with her indomitable spirit, and tells others, “My advice about the best way to handle something is to look at it positively. I looked at cancer as a blessing because it taught me more about myself. It also allowed me to raise awareness that cancer is survivable.”

For more information, visit http://www.anastacia.com.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap